Bill > S2686

This bill, the Suspicious Order Identification Act of 2019, aims to improve the reporting of the distribution of controlled substances. The key provisions of the bill include: 1. Requiring registrants (manufacturers, distributors, and others registered under the Controlled Substances Act) to report every sale, delivery, or other disposal of controlled substances to the Attorney General in real-time or within 30 days. 2. Establishing a Suspicious Order Monitoring Task Force, comprising representatives from various federal agencies, to design and implement a program for sharing real-time data with registrants to help them identify suspicious orders. 3. Authorizing the Attorney General to use fees collected from registrants to fund the implementation of the real-time data sharing program. 4. Requiring all registered drug manufacturers and distributors to review the information made available through the program and comply with any related regulations. The bill is intended to enhance the monitoring and identification of suspicious orders of controlled substances, with the goal of reducing the diversion of these substances and addressing the opioid crisis.

Justice

https://www.congress.gov/bill/116th-congress/senate-bill/2686/all-info